JP2016041072A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016041072A5 JP2016041072A5 JP2015206999A JP2015206999A JP2016041072A5 JP 2016041072 A5 JP2016041072 A5 JP 2016041072A5 JP 2015206999 A JP2015206999 A JP 2015206999A JP 2015206999 A JP2015206999 A JP 2015206999A JP 2016041072 A5 JP2016041072 A5 JP 2016041072A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- alpha
- oligodextran
- subject
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 35
- 230000009286 beneficial effect Effects 0.000 claims 10
- 238000000034 method Methods 0.000 claims 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 7
- 229930006000 Sucrose Natural products 0.000 claims 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 7
- 239000008103 glucose Substances 0.000 claims 7
- 230000002265 prevention Effects 0.000 claims 7
- 239000005720 sucrose Substances 0.000 claims 7
- 230000036541 health Effects 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 6
- 108010048202 alternansucrase Proteins 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 5
- 108010042194 dextransucrase Proteins 0.000 claims 5
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 5
- 235000013406 prebiotics Nutrition 0.000 claims 4
- 239000007858 starting material Substances 0.000 claims 3
- 241000186660 Lactobacillus Species 0.000 claims 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 230000003247 decreasing effect Effects 0.000 claims 2
- 230000002255 enzymatic effect Effects 0.000 claims 2
- 239000000835 fiber Substances 0.000 claims 2
- 229940050549 fiber Drugs 0.000 claims 2
- 230000012010 growth Effects 0.000 claims 2
- 235000000346 sugar Nutrition 0.000 claims 2
- 230000004584 weight gain Effects 0.000 claims 2
- 235000019786 weight gain Nutrition 0.000 claims 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims 1
- 208000004998 Abdominal Pain Diseases 0.000 claims 1
- 206010000060 Abdominal distension Diseases 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 241000186000 Bifidobacterium Species 0.000 claims 1
- 229920002307 Dextran Polymers 0.000 claims 1
- 229920001353 Dextrin Polymers 0.000 claims 1
- 239000004375 Dextrin Substances 0.000 claims 1
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 claims 1
- 229920002488 Hemicellulose Polymers 0.000 claims 1
- 108091016366 Histone-lysine N-methyltransferase EHMT1 Proteins 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 229920001202 Inulin Polymers 0.000 claims 1
- 102000007330 LDL Lipoproteins Human genes 0.000 claims 1
- 108010007622 LDL Lipoproteins Proteins 0.000 claims 1
- 229920002774 Maltodextrin Polymers 0.000 claims 1
- 239000005913 Maltodextrin Substances 0.000 claims 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 229920001100 Polydextrose Polymers 0.000 claims 1
- 229920001218 Pullulan Polymers 0.000 claims 1
- 239000004373 Pullulan Substances 0.000 claims 1
- 229920000294 Resistant starch Polymers 0.000 claims 1
- 241000235070 Saccharomyces Species 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- 241000194017 Streptococcus Species 0.000 claims 1
- 240000008042 Zea mays Species 0.000 claims 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 210000000577 adipose tissue Anatomy 0.000 claims 1
- 230000000202 analgesic effect Effects 0.000 claims 1
- 208000024330 bloating Diseases 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 235000005822 corn Nutrition 0.000 claims 1
- 235000019425 dextrin Nutrition 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 235000013325 dietary fiber Nutrition 0.000 claims 1
- 230000001079 digestive effect Effects 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 235000012041 food component Nutrition 0.000 claims 1
- 239000005417 food ingredient Substances 0.000 claims 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims 1
- 229940107187 fructooligosaccharide Drugs 0.000 claims 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims 1
- 150000003271 galactooligosaccharides Chemical class 0.000 claims 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 238000006206 glycosylation reaction Methods 0.000 claims 1
- 244000005709 gut microbiome Species 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 230000003914 insulin secretion Effects 0.000 claims 1
- 230000007413 intestinal health Effects 0.000 claims 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims 1
- 229940029339 inulin Drugs 0.000 claims 1
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 claims 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 claims 1
- 229960000511 lactulose Drugs 0.000 claims 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 claims 1
- 210000002429 large intestine Anatomy 0.000 claims 1
- 229940035034 maltodextrin Drugs 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000001259 polydextrose Substances 0.000 claims 1
- 235000013856 polydextrose Nutrition 0.000 claims 1
- 229940035035 polydextrose Drugs 0.000 claims 1
- 239000006041 probiotic Substances 0.000 claims 1
- 230000000529 probiotic effect Effects 0.000 claims 1
- 235000018291 probiotics Nutrition 0.000 claims 1
- 235000019423 pullulan Nutrition 0.000 claims 1
- 235000018770 reduced food intake Nutrition 0.000 claims 1
- 235000021254 resistant starch Nutrition 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 235000021391 short chain fatty acids Nutrition 0.000 claims 1
- 150000004666 short chain fatty acids Chemical class 0.000 claims 1
- 210000000813 small intestine Anatomy 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
- 208000009935 visceral pain Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17624209P | 2009-05-07 | 2009-05-07 | |
| US61/176,242 | 2009-05-07 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012509997A Division JP6077303B2 (ja) | 2009-05-07 | 2010-05-07 | アルファ−（１，２）−分岐アルファ−（１，６）オリゴデキストランを含有する組成物及びアルファ−（１，２）−分岐アルファ−（１，６）オリゴデキストランの製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016041072A JP2016041072A (ja) | 2016-03-31 |
| JP2016041072A5 true JP2016041072A5 (enExample) | 2016-08-18 |
| JP6144745B2 JP6144745B2 (ja) | 2017-06-07 |
Family
ID=42236313
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012509997A Active JP6077303B2 (ja) | 2009-05-07 | 2010-05-07 | アルファ−（１，２）−分岐アルファ−（１，６）オリゴデキストランを含有する組成物及びアルファ−（１，２）−分岐アルファ−（１，６）オリゴデキストランの製造方法 |
| JP2015206999A Active JP6144745B2 (ja) | 2009-05-07 | 2015-10-21 | アルファ−（１，２）−分岐アルファ−（１，６）オリゴデキストランを含有する組成物及びアルファ−（１，２）−分岐アルファ−（１，６）オリゴデキストランの製造方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012509997A Active JP6077303B2 (ja) | 2009-05-07 | 2010-05-07 | アルファ−（１，２）−分岐アルファ−（１，６）オリゴデキストランを含有する組成物及びアルファ−（１，２）−分岐アルファ−（１，６）オリゴデキストランの製造方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US8816067B2 (enExample) |
| EP (1) | EP2427499A1 (enExample) |
| JP (2) | JP6077303B2 (enExample) |
| KR (1) | KR101783383B1 (enExample) |
| CN (1) | CN102439048B (enExample) |
| AU (1) | AU2010245761B2 (enExample) |
| BR (1) | BRPI1014800A8 (enExample) |
| CA (1) | CA2761150C (enExample) |
| IL (1) | IL215936A (enExample) |
| MX (1) | MX2011011659A (enExample) |
| WO (1) | WO2010129839A1 (enExample) |
Families Citing this family (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101783383B1 (ko) | 2009-05-07 | 2017-09-29 | 테이트 ＆ 라일 인그레디언츠 프랑스 에스에이에스 | 알파-(1,2)-분지형 알파-(1,6) 올리고덱스트란을 제조하기 위한 조성물 및 방법 |
| CN103068254A (zh) * | 2010-08-25 | 2013-04-24 | 泰特&莱尔组分美国公司 | 合生素产品 |
| GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| MX2014005433A (es) * | 2011-11-04 | 2014-08-22 | Gen Mills Inc | Métodos y composiciones para modular bacterias gastrointestinales para promover la salud. |
| CN104363769B (zh) * | 2012-02-28 | 2016-08-24 | 康奈尔大学 | 益生菌组合物和方法 |
| IN2014DN07752A (enExample) | 2012-02-29 | 2015-05-15 | Ethicon Endo Surgery Inc | |
| KR101381794B1 (ko) * | 2012-04-10 | 2014-04-07 | 씨제이제일제당 (주) | 타가토스 및 프로바이오틱 유산균을 함유하는 신바이오틱 식품 조성물 |
| WO2014007606A1 (en) * | 2012-07-05 | 2014-01-09 | N.V. Nutricia | Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour |
| US20150296851A1 (en) * | 2012-11-27 | 2015-10-22 | Shanghai Jiao Tong University | Compositions for Balancing Gut Microbiota and the Preparation and the Uses thereof |
| WO2014107657A2 (en) * | 2013-01-04 | 2014-07-10 | Kohn Kenneth I | Cholesterol-lowering compounds in combination with lipid metabolism-altering compounds of non-absorbable sugars, compounds that convert nh3 to nh4+, or hydrogen-generating compounds for the treatment of high cholesterol and inflammation |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| AU2015223025B2 (en) * | 2014-02-27 | 2018-09-20 | Nutrition & Biosciences USA 4, Inc. | Enzymatic hydrolysis of disaccharides and oligosaccharides using alpha-glucosidase enzymes |
| WO2015183721A1 (en) | 2014-05-29 | 2015-12-03 | E. I. Du Pont De Nemours And Company | Enzymatic synthesis of soluble glucan fiber |
| MX2016015604A (es) * | 2014-05-29 | 2017-07-04 | Du Pont | Síntesis enzimática de fibra soluble de glucano. |
| CN106536569A (zh) | 2014-05-29 | 2017-03-22 | 纳幕尔杜邦公司 | 可溶性葡聚糖纤维的酶促合成 |
| WO2015183724A1 (en) | 2014-05-29 | 2015-12-03 | E. I. Du Pont De Nemours And Company | Enzymatic synthesis of soluble glucan fiber |
| BR112016027839A2 (pt) | 2014-05-29 | 2017-10-31 | Du Pont | composições de fibra e de carboidrato, produto alimentício, métodos de produção de composição de fibra, de elaboração de composição de carboidrato misturada, de redução do índice glicêmico de alimentos ou bebidas e de inibição da elevação do nível de açúcar no sangue, composição cosmética, uso da composição de fibra e produto |
| CN106414506A (zh) * | 2014-05-29 | 2017-02-15 | 纳幕尔杜邦公司 | 可溶性葡聚糖纤维的酶促合成 |
| US10752705B2 (en) | 2014-07-09 | 2020-08-25 | Cadena Bio, Inc. | Oligosaccharide compositions and methods for producing thereof |
| FR3024158A1 (fr) * | 2014-07-28 | 2016-01-29 | Inst Nat Sciences Appliq | Proteine a activite dextrane-saccharase et applications |
| US10702545B2 (en) | 2014-09-22 | 2020-07-07 | Nihon Shokuhin Co., Ltd. | Slowly digestible, sustained-type energy supplying agent |
| SG10201903823QA (en) | 2014-10-31 | 2019-05-30 | Whole Biome Inc | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| US20160165941A1 (en) * | 2014-11-21 | 2016-06-16 | Flipn'Sweet, LLC | Sugar substitute compositions comprising digestion resistent soluble fiber |
| US9968910B2 (en) | 2014-12-22 | 2018-05-15 | E I Du Pont De Nemours And Company | Polysaccharide compositions for absorbing aqueous liquid |
| ES2658310T3 (es) | 2014-12-23 | 2018-03-09 | 4D Pharma Research Limited | Una cepa de bacteroides thetaiotaomicron y su uso en la reducción de la inflamación |
| EP3193901B1 (en) | 2014-12-23 | 2018-04-04 | 4D Pharma Research Limited | Pirin polypeptide and immune modulation |
| ES2857557T3 (es) | 2015-01-26 | 2021-09-29 | Kaleido Biosciences Inc | Compuestos terapéuticos de glicano y métodos relacionados de los mismos |
| EP4205553A1 (en) | 2015-01-26 | 2023-07-05 | DSM Nutritional Products, LLC | Oligosaccharide compositions for use animal feed and methods of producing thereof |
| CA2983236A1 (en) | 2015-04-23 | 2016-10-27 | Kaleido Biosciences, Inc. | Glycan therapeutics and methods of treatment |
| PT3307288T (pt) | 2015-06-15 | 2019-10-17 | 4D Pharma Res Ltd | Composições compreendendo estirpes bacterianas |
| MA55434B1 (fr) | 2015-06-15 | 2022-02-28 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| TWI759266B (zh) | 2015-06-15 | 2022-04-01 | 英商4D製藥研究有限公司 | 包含細菌菌株之組合物之用途 |
| MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| WO2017079595A1 (en) * | 2015-11-05 | 2017-05-11 | E. I. Du Pont De Nemours And Company | Dextran-poly alpha-1,3-glucan graft copolymers and synthesis methods thereof |
| JP2019504932A (ja) | 2015-11-13 | 2019-02-21 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ | 洗濯ケアおよび織物ケアにおいて使用するためのグルカン繊維組成物 |
| WO2017083226A1 (en) | 2015-11-13 | 2017-05-18 | E. I. Du Pont De Nemours And Company | Glucan fiber compositions for use in laundry care and fabric care |
| JP7045313B2 (ja) | 2015-11-13 | 2022-03-31 | ニュートリション・アンド・バイオサイエンシーズ・ユーエスエー・フォー，インコーポレイテッド | 洗濯ケアおよび織物ケアにおいて使用するためのグルカン繊維組成物 |
| MA45287A (fr) | 2015-11-20 | 2018-08-22 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| CA3002666A1 (en) * | 2015-11-26 | 2017-06-01 | Qiong Cheng | Polypeptides capable of producing glucans having alpha-1,2 branches and use of the same |
| WO2017127436A1 (en) * | 2016-01-18 | 2017-07-27 | Isothrive Llc | Maltosyl-isomaltooligosaccharides |
| EP3421041A4 (en) * | 2016-02-24 | 2019-11-27 | Nitto Pharmaceutical Industries, Ltd. | COMPOSITION FOR THE PREVENTION OR TREATMENT OF METABOLISM DISEASES WITH LEUCONOSTOC MESENTEROIDES-PRODUCING EXOPOLYSACCHARIDES AS AN ACTIVE SUBSTANCE |
| GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
| PT3313423T (pt) | 2016-03-04 | 2019-07-10 | 4D Pharma Plc | Composições que compreendem a estirpe blautia bacteriana para tratar a hipersensibilidade visceral |
| TWI802545B (zh) | 2016-07-13 | 2023-05-21 | 英商４Ｄ製藥有限公司 | 包含細菌菌株之組合物 |
| ES2967947T3 (es) * | 2016-12-06 | 2024-05-06 | Dsm Nutritional Products Llc | Polímeros de glicano y métodos relacionados de los mismos |
| GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
| RS61872B1 (sr) | 2017-05-22 | 2021-06-30 | 4D Pharma Res Ltd | Kompozicije koje sadrže bakterijske sojeve |
| WO2018215782A1 (en) | 2017-05-24 | 2018-11-29 | 4D Pharma Research Limited | Compositions comprising bacterial strain |
| JP6840272B2 (ja) | 2017-06-14 | 2021-03-10 | フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ | 細菌株を含む組成物 |
| RS63393B1 (sr) | 2017-06-14 | 2022-08-31 | 4D Pharma Res Ltd | Kompozicije koje sadrže bakterijske sojeve |
| EP3638271B1 (en) | 2017-06-14 | 2020-10-14 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| WO2019046646A1 (en) | 2017-08-30 | 2019-03-07 | Whole Biome Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS |
| EP3703705B1 (en) | 2017-11-03 | 2024-05-15 | DSM Nutritional Products, LLC | Glucose-containing glycan preparations for use in the treatment of hyperammonaemia |
| EP3720967A4 (en) * | 2017-12-08 | 2021-09-08 | Isothrive Inc. | METHOD FOR PRODUCING MALTOSYL ISOMALTOOLIGOSACCHARIDES (MIMO) |
| CN108191987B (zh) * | 2017-12-28 | 2022-01-14 | 山东百龙创园生物科技股份有限公司 | 一种抗性淀粉的制备方法 |
| WO2019165060A1 (en) | 2018-02-23 | 2019-08-29 | Danisco Us Inc | Synthesis of glucan comprising alpha-1,3 glycosidic linkages with phosphorylase enzymes |
| CN108912410A (zh) * | 2018-06-24 | 2018-11-30 | 袁暾 | 一种含茶提取物的β-葡聚糖胶体 |
| CN113164526A (zh) | 2018-07-19 | 2021-07-23 | 潘德勒姆治疗公司 | 用于微生物植入的方法和组合物 |
| US20200113858A1 (en) * | 2018-10-15 | 2020-04-16 | Freedom Health, Llc | Human dietary supplement and method for treating digestive system and immune-related disorders |
| US20220233560A1 (en) * | 2019-05-08 | 2022-07-28 | Kaleido Biosciences, Inc. | Oligosaccharide compositions and methods of use |
| EP4181910A4 (en) * | 2020-07-17 | 2024-06-05 | DSM Nutritional Products, LLC | OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE |
| CN112553271A (zh) * | 2020-12-15 | 2021-03-26 | 江南大学 | 一种含α-1,2糖苷键低热量糊精的制备方法 |
| KR20240131494A (ko) | 2023-02-23 | 2024-09-02 | 유선균 | 웨이셀라 시바리아 ysk01 균주 및 이의 용도 |
| KR20240161925A (ko) | 2023-05-04 | 2024-11-13 | 단국대학교 천안캠퍼스 산학협력단 | 류코노스톡 메젠테로이드 mksr 유래 당전이 효소로 제조된 신규 당류, 이의 용도 및 이의 제조 방법 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB749515A (en) | 1953-03-19 | 1956-05-30 | Dextran Ltd | Improvements in or relating to the production of dextran |
| FR2626583B1 (fr) | 1988-01-29 | 1991-03-15 | Bioeurope | Procede de preparation enzymatique d'oligodextranes utiles dans la fabrication de substituts du sucre, et nouveaux oligodextranes |
| JP3503238B2 (ja) | 1995-01-09 | 2004-03-02 | ソニー株式会社 | 適応型制御装置 |
| KR100501584B1 (ko) * | 2000-02-03 | 2005-07-18 | (주)케이비피 | 저분자 폴리만유로네이트의 제조방법, 혈청지질개선제로서의 이의 신규 용도 및 이를 함유하는 기능성식품 및 건강 보조 식품 |
| DE10105305A1 (de) * | 2001-02-02 | 2002-08-14 | Nutrinova Gmbh | Sorbinsäurepräparat als Futtermittelzusatz in der Nutztieraufzucht |
| FR2822163B3 (fr) | 2001-03-16 | 2003-06-13 | Centre Nat Rech Scient | Molecules d'acides nucleiques codant une dextrane-saccharase catalysant la synthese de dextrane portant des ramifications de type alpha-1,2 osidiques |
| FR2822162B1 (fr) | 2001-03-16 | 2003-06-27 | Inst Nat Sciences Appliq | Molecules d'acides nucleiques codant une dextrane-saccharase calatalysant la synthese de dextrane portant des ramifications de type alpha-1,2 osidiques |
| AU2002951270A0 (en) | 2002-09-06 | 2002-09-19 | Vri Biomedical Ltd | Probiotic Bacterium and Methods of Use |
| FR2844453B1 (fr) | 2002-09-13 | 2006-05-19 | Agronomique Inst Nat Rech | Utilisation de pre-biotiques pour la prevention de l'installation du diabete de type ii |
| CN1690085A (zh) * | 2004-04-30 | 2005-11-02 | 天津振和生物工程有限公司 | 一种水溶性多聚糖及其生产方法 |
| FR2875406B1 (fr) | 2004-09-21 | 2007-01-05 | Danisco | Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal |
| FR2897069B1 (fr) | 2006-02-08 | 2012-06-08 | Centre Nat Rech Scient | Construction de nouveaux variants de l'enzyme dextrane-saccharase dsr-s par ingienerie moleculaire. |
| WO2008054193A1 (en) * | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Nutritional products that comprise saccharide oligomers |
| EP1972208A1 (en) | 2007-03-16 | 2008-09-24 | Kirin Holdings Kabushiki Kaisha | Composition for improving intestinal microflora |
| AU2008267279B2 (en) | 2007-06-25 | 2014-02-27 | Dsm Ip Assets B.V. | Novel prebiotics |
| KR101783383B1 (ko) * | 2009-05-07 | 2017-09-29 | 테이트 ＆ 라일 인그레디언츠 프랑스 에스에이에스 | 알파-(1,2)-분지형 알파-(1,6) 올리고덱스트란을 제조하기 위한 조성물 및 방법 |
-
2010
- 2010-05-07 KR KR1020117029265A patent/KR101783383B1/ko active Active
- 2010-05-07 CN CN201080020234.2A patent/CN102439048B/zh active Active
- 2010-05-07 CA CA2761150A patent/CA2761150C/en active Active
- 2010-05-07 JP JP2012509997A patent/JP6077303B2/ja active Active
- 2010-05-07 MX MX2011011659A patent/MX2011011659A/es active IP Right Grant
- 2010-05-07 US US12/775,656 patent/US8816067B2/en active Active
- 2010-05-07 AU AU2010245761A patent/AU2010245761B2/en active Active
- 2010-05-07 WO PCT/US2010/033984 patent/WO2010129839A1/en not_active Ceased
- 2010-05-07 EP EP10718007A patent/EP2427499A1/en not_active Withdrawn
- 2010-05-07 BR BRPI1014800A patent/BRPI1014800A8/pt not_active Application Discontinuation
-
2011
- 2011-10-25 IL IL215936A patent/IL215936A/en active IP Right Grant
-
2014
- 2014-07-11 US US14/329,549 patent/US9512239B2/en active Active
-
2015
- 2015-10-21 JP JP2015206999A patent/JP6144745B2/ja active Active
-
2016
- 2016-10-21 US US15/331,223 patent/US10167346B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016041072A5 (enExample) | ||
| JP6077303B2 (ja) | アルファ−（１，２）−分岐アルファ−（１，６）オリゴデキストランを含有する組成物及びアルファ−（１，２）−分岐アルファ−（１，６）オリゴデキストランの製造方法 | |
| AU2008262670B2 (en) | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide | |
| EP3932410B1 (en) | Mixture of non-digestible oligosaccharides for stimulating the immune system | |
| US8227448B2 (en) | Nutritional composition with health promoting action containing oligosaccharides | |
| AU2006237736B2 (en) | Uronic acid and probiotics | |
| CN1105506C (zh) | 碳水化合物混合物 | |
| KR102080562B1 (ko) | 혈당강하 고분지형 말토덱스트린 | |
| JP2005531611A5 (enExample) | ||
| TW201233334A (en) | Human milk oligosaccharides to promote growth of beneficial bacteria | |
| CA2626398A1 (en) | Dietary fiber formulation and method of administration | |
| WO2010143940A1 (en) | Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages | |
| CN105744938A (zh) | 用于预防或治疗婴儿和幼儿的坏死性小肠结肠炎的组合物 | |
| CN116615116A (zh) | 幼儿纤维混合物 | |
| Glibowski et al. | Prebiotic and synbiotic foods | |
| TW202102210A (zh) | 改善腸道障蔽功能用組成物 | |
| Crittenden | Emerging prebiotic carbohydrates | |
| Malinowska-Pańczyk | Probiotics and Prebiotics in Food | |
| KR20220155007A (ko) | 아세틸아디핀산이전분을 포함하는 장내 균총 개선용 조성물 | |
| CN117297013A (zh) | 复合益生元固体饮料 | |
| Haskoylu et al. | Fructan rich diet to improve gut microbiota in disease and health |